Behind Our Science

Behind Our Science Podcast aims to close the gap in understanding the complex mechanisms driving disease formation and engage the general public and research advocates. We will engage the public by explaining the latest exciting biomedical innovations in simple terms free from jargon and emphasize the importance of supporting continued research in the biomedical sciences. We will explain the importance of how understanding fundamental mechanisms driving diseases provides a solid foundation for breakthroughs in scientific research.https://asippathways.com/behind-our-science/

All Episodes

Behind Our Science

Episode 8-2022: Celebrating Black History Month

February 28, 2022 • Behind Our Science • Season 2 • Episode 8

On this our episode 8 we celebrate #BlackHistoryMonth by highlighting very brilliant Black scientists and researchers. We also have article highlights, 7.3 Q's with Daisy Shu and a crossover interview with People of Pathology podcast. ENJOY!!!

1st segment: 1 on 1 interview with Dr. Bryan Wilson, PhD, MBA with Dr. Roberto Mota
2nd segment: Article Highlights "On Being Black in the Ivory Tower" published in Cell, "Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19" published in Current Pathobiology Reports, and "Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens" published in American Journal of Pathology with Dr. Vik Meadows
3rd segment: 7.3 Q's with Dr. Tessa Fitch with Dr. Daisy Shu
4th segment: Crossover interview with Dennis Strenk from "People of Pathology" Podcast & 7.3 questions segment with Dr. Roberto Mota

Producers and co-host:
Roberto Mota Alvidrez
Daisy Shu
Vik Meadows
Marina Anastasiou

Editor: Jeff Jenkins
Music: Jeff Jenkins, Roberto Mota, Azael Frayre

Thank you to the American Society for Investigative Pathology and the Histochemical Society

Articles cited:
1. Armstrong A, Lomax J, Traylor-Knowles N, Samba-Louaka A, Towers C. On Being Black in the Ivory Tower. Cell. 2020 Oct 29;183(3):559-560. doi: 10.1016/j.cell.2020.10.006. PMID: 33125879.
2. Julian DR, Kazakoff MA, Patel A, Jaynes J, Willis MS, Yates CC. Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19. Curr Pathobiol Rep. 2021;9(4):93-105. doi: 10.1007/s40139-021-00226-0. Epub 2021 Dec 8. PMID: 34900402; PMCID: PMC8651461.
3. Valestrand L, Zheng F, Hansen SH, Øgaard J, Hov JR, Björkström NK, Karlsen TH, Jiang X, Melum E. Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens. Am J Pathol. 2022 Jan 19:S0002-9440(22)00008-6. doi: 10.1016/j.ajpath.2021.12.008. Epub ahead of print. PMID: 35063408.